Loading organizations...
Alwyn Capital is a venture capital firm exclusively investing in groundbreaking biotechnology. It targets companies developing solutions to eliminate animal reliance in food, fashion, and pharmaceuticals. This strategic approach champions scientific advancements, providing sustainable, efficient alternatives to conventional animal-based industrial processes.
Heather Courtney founded Alwyn Capital in 2018; Robert Dupree later joined. Courtney’s insight derived from science driving a sustainable future. Her pharmaceutical research exposed animal testing inefficiencies, solidifying commitment to funding biotech solutions improving human outcomes by eliminating outdated methodologies.
The firm backs innovative biotech companies and founders with crucial capital and strategic guidance. Alwyn Capital envisions a future reshaped by biotechnological innovation, promoting heightened efficiency and sustainability. Its long-term mission involves making substantial positive impact on global well-being by championing superior, animal-free alternatives.
Alwyn Capital has 2 tracked investments across 2 companies. The latest tracked deal is $1.2M Seed in Atlantic Fish Company in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 4, 2025 | Atlantic Fish Company | $1.2M Seed | — | SAM Selig |
| Sep 1, 2022 | Bucha Bio | $1.0M Seed | — | Alumni Ventures, B Capital Group, NEW Climate Ventures, Prithvi Ventures, SOSV, Chris Zarou, Asymmetry Ventures, Beni VC, Lifely VC |
